Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma

HIRONORI SHIOZAKI, KENEI FURUKAWA, KOICHIRO HARUKI, MICHINORI MATSUMOTO, TADASHI UWAGAWA, SHINJI ONDA, YUTO YAMAHATA, SHUNTA ISHIZAKI, KYOHEI ABE, SHUICHI FUJIOKA, YUICHI NAKASEKO, TOMOYOSHI OKAMOTO and TORU IKEGAMI
Anticancer Research April 2023, 43 (4) 1761-1766; DOI: https://doi.org/10.21873/anticanres.16329
HIRONORI SHIOZAKI
1Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hironori525@hotmail.co.jp
KENEI FURUKAWA
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOICHIRO HARUKI
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MICHINORI MATSUMOTO
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADASHI UWAGAWA
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHINJI ONDA
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTO YAMAHATA
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUNTA ISHIZAKI
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KYOHEI ABE
3Department of Surgery, The Jikei University Kashiwa Hospital, Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUICHI FUJIOKA
3Department of Surgery, The Jikei University Kashiwa Hospital, Chiba, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHI NAKASEKO
4Department of Surgery, The International University of Health and Welfare, Tochigi, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOYOSHI OKAMOTO
1Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU IKEGAMI
2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 43 no. 4 1761-1766
DOI 
https://doi.org/10.21873/anticanres.16329
PubMed 
36974796

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received December 21, 2022
  • Revision received January 28, 2023
  • Accepted February 2, 2023
  • Published online March 27, 2023.

Copyright & Usage 
Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. HIRONORI SHIOZAKI1⇑,
  2. KENEI FURUKAWA2,
  3. KOICHIRO HARUKI2,
  4. MICHINORI MATSUMOTO2,
  5. TADASHI UWAGAWA2,
  6. SHINJI ONDA2,
  7. YUTO YAMAHATA2,
  8. SHUNTA ISHIZAKI2,
  9. KYOHEI ABE3,
  10. SHUICHI FUJIOKA3,
  11. YUICHI NAKASEKO4,
  12. TOMOYOSHI OKAMOTO1 and
  13. TORU IKEGAMI2
  1. 1Department of Surgery, The Jikei University Daisan Hospital, Tokyo, Japan;
  2. 2Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan;
  3. 3Department of Surgery, The Jikei University Kashiwa Hospital, Chiba, Japan;
  4. 4Department of Surgery, The International University of Health and Welfare, Tochigi, Japan
  1. Correspondence to: Hironori Shiozaki, MD, Department of Surgery, The Jikei University Daisan Hospital, 4-11-1 Izumihonchou, Komae-shi, Tokyo 201-8601, Japan. Tel: +81 334801151, Fax: +81 334303611, e-mail: hironori525{at}hotmail.co.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • 4 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Drug Resistance in Hepatocellular Carcinoma: Theoretical Basis and Therapeutic Aspects
    Ya-ruo Lei, Xian-lu He, Jun Li, Chun-fen Mo
    Frontiers in Bioscience-Landmark 2024 29 2
  • Chinese Multidisciplinary Expert Consensus on Immune Checkpoint Inhibitor-Based Combination Therapy for Hepatocellular Carcinoma (2023 Edition)
    Xiufeng Liu, Yinying Lu, Weiping Zhou, Tao Peng, Jie Zhou, Huaqiang Bi, Feng Xia, Xiaoping Chen
    Liver Cancer 2024 13 4
  • A patient alive without disease 32 months after conversion surgery following lenvatinib treatment for hepatocellular carcinoma with a tumor thrombus originating in the middle hepatic vein and reaching the right atrium via the suprahepatic vena cava: a case report
    Yu Gyoda, Hirofumi Ichida, Fumihiro Kawano, Yoshinori Takeda, Ryuji Yoshioka, Hiroshi Imamura, Yoshihiro Mise, Yuki Fukumura, Akio Saiura
    Clinical Journal of Gastroenterology 2024 17 2
  • Hepatocellular carcinoma converted from atezolizumab and bevacizumab combination therapy: a case report
    Keisuke Ida, Satoshi Koizumi, Atsuhito Tsuchihashi, Shinjiro Kobayashi, Takehito Otsubo
    Oxford Medical Case Reports 2024 2024 12
PreviousNext
Back to top

In this issue

Anticancer Research: 43 (4)
Anticancer Research
Vol. 43, Issue 4
April 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma
HIRONORI SHIOZAKI, KENEI FURUKAWA, KOICHIRO HARUKI, MICHINORI MATSUMOTO, TADASHI UWAGAWA, SHINJI ONDA, YUTO YAMAHATA, SHUNTA ISHIZAKI, KYOHEI ABE, SHUICHI FUJIOKA, YUICHI NAKASEKO, TOMOYOSHI OKAMOTO, TORU IKEGAMI
Anticancer Research Apr 2023, 43 (4) 1761-1766; DOI: 10.21873/anticanres.16329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
A Multidisciplinary Treatment Strategy With Conversion Surgery for Hepatocellular Carcinoma
HIRONORI SHIOZAKI, KENEI FURUKAWA, KOICHIRO HARUKI, MICHINORI MATSUMOTO, TADASHI UWAGAWA, SHINJI ONDA, YUTO YAMAHATA, SHUNTA ISHIZAKI, KYOHEI ABE, SHUICHI FUJIOKA, YUICHI NAKASEKO, TOMOYOSHI OKAMOTO, TORU IKEGAMI
Anticancer Research Apr 2023, 43 (4) 1761-1766; DOI: 10.21873/anticanres.16329
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Safety and Feasibility of Laparoscopic Anatomical Liver Resection for Hepatocellular Carcinoma: A Propensity Score-matched Study
  • Google Scholar

More in this TOC Section

  • Gastrojejunostomy for Asymptomatic Gastric Outlet Obstruction in Pancreatic Cancer May Contribute to Early Recovery
  • Feasibility of an Exercise Training Program Among Patients With Newly Diagnosed Advanced Breast Cancer
  • Impact of Surgery Refusal on Overall Survival in Merkel Cell Carcinoma
Show more Clinical Studies

Similar Articles

Keywords

  • conversion surgery
  • lenvatinib
  • Hepatocellular carcinoma
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire